How Conducting a Clinical Trial Affects Physicians' Guideline Adherence and Drug Preferences
JAMAPublished 20 June 2006
Morten Andersen, Jakob Kragstrup, Jens Søndergaard
Citations91
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
Conducting a trial sponsored by a pharmaceutical company had no significant impact on physicians' adherence to international treatment recommendations but increased their use of the trial sponsor's drugs.
Keywords
MedicineHealth ProfessionsPharmacology, Toxicology and Pharmaceutics
Statistical ScienceBootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy
6,106 Citations1986B. Efron, R. Tibshirani
The bootstrap is extended to other measures of statistical accuracy such as bias and prediction error, and to complicated data structures such as time series, censored data, and regression models.
BMJAnalysing controlled trials with baseline and follow up measurements
1,902 Citations2001Andrew J. Vickers, Douglas G. Altman
In many randomised trials researchers measure a continuous variable at baseline and again as an outcome assessed at follow up to see whether a treatment can reduce pre-existing levels of pain, anxiety, hypertension, and the like.
JAMAPhysicians and the Pharmaceutical Industry
1,398 Citations2000Ashley Wazana
The present extent of physician-industry interactions appears to affect prescribing and professional behavior and should be further addressed at the level of policy and education.
The American Journal of MedicineScientific versus commercial sources of influence on the prescribing behavior of physicians
570 Citations1982Jerry Avorn, Milton Chen +1 more
To study the relative contributions of scientific and commercial sources of information, two index drugs were chosen, whose pharmacologic effects have been shown by controlled studies to be minimal or not significantly different from those of nonprescription (over-thecounter) preparations, but which are heavily advertised as being effective.
Social Science & MedicineThe role of commercial sources in the adoption of a new drug
144 Citations1988Marilyn Y. Peay, Edmund R. Peay
Results suggest that the adoption of the new drug was related to commercial forces rather than to a doctor's professional involvements.
The LancetRising prevalence of diabetes: evidence from a Danish pharmacoepidemiological database.
93 Citations2003Henrik Støvring, Morten Andersen +3 more
Although prevalence of drug-treated diabetes increased, mortality in those treated declined and future research into the causes of rising diabetes prevalence should take this fall in mortality into account to avoid incorrect conclusions about the relation between western lifestyle and the growing number of diabetics.
Pharmacoepidemiology and Drug SafetyConducting pharmacoepidemiologic research in Denmark
70 Citations2001Jesper Hallas
Denmark has one of the worlds most comprehensive registration of its citizens' use of medical and social services and most databases are population‐based and of very high quality.
European Journal of Clinical PharmacologyDetailed postal feedback about prescribing to asthma patients combined with a guideline statement showed no impact: a randomised controlled trial
44 Citations2002Jens Søndergaard, Morten Andersen +4 more
Mailed prescriber feedback of detailed and clinically relevant data with a guideline statement, without revealing patient identities, has little or no impact on prescribing patterns.
Social Science & MedicineEffects of promotion on pharmaceutical demand
31 Citations1985John I. Mackowiak, Jean Paul Gagnon
Drug manufacturers should evaluate the effects of reductions in their promotional expenditures, changes in promotional content, as well as seek alternative methods of advertising which may have a higher sales elasticity and effectiveness.
European Journal of Clinical PharmacologyImpact of clinical trials on the adoption of new drugs within a university hospital
24 Citations1991Petra Denig, F. M. Haaijer-Ruskamp +2 more
A significant relation was found between the testing of semi-innovative drugs in clinical trials in the hospital and the introduction of these drugs into general use in the same hospital and no such relationship was found for innovative drugs.
British Journal of Clinical PharmacologySleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice
13 Citations2000Nick Freemantle, Richard E. Johnson +3 more
Health authorities can achieve professional working relationships with the pharmaceutical industry although no changes in practice attributable to the intervention are achieved and further work is required to develop effective means to influence prescribing in line with independent guidelines.